Effects of Semaglutide in HIV-Associated Lipohypertrophy

NCT04019197 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS
Lipohypertrophy
Obesity

Interventions

DRUG: Semaglutide Injectable Product
DRUG: Placebo

Sponsor

Case Western Reserve University

Collaborators

[object Object]
[object Object]